Skip to main content
Premium Trial:

Request an Annual Quote

PNNL Wins $10.3M NIH Biodefense Proteomics Contract

NEW YORK, Sept. 13 (GenomeWeb News) - Researchers at Pacific Northwest National Laboratory in Richland, Wash., have won a $10.3 million biodefense proteomics contract from the National Institute of Allergies and Infectious Agents, PNNL said last week..

 

Under the five-year contract, scientists led by Richard Smith will analyze the proteins of orthopox viruses, Salmonella typhimurium, and Salmonella typhi using proteomics techniques.

 

Collaborators at OregonHealthSciencesUniversity in Portland will prepare the microbial samples, which will be analyzed by researchers at PNNL to determine which microbial proteins interact with which human host cells proteins.

 

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.